InnoScience (Suzhou) Technology Holding Co., Ltd. (HKG:2577) Just Released Its Half-Year Earnings: Here's What Analysts Think
InnoScience (Suzhou) Technology Holding Co., Ltd. (HKG:2577) came out with its half-yearly results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.
Following the latest results, InnoScience (Suzhou) Technology Holding's eight analysts are now forecasting revenues of CN¥2.16b in 2026. This would be a substantial 45% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 24% to CN¥0.60. Before this latest report, the consensus had been expecting revenues of CN¥2.18b and CN¥0.65 per share in losses. It looks like there's been a modest increase in sentiment in the recent updates, with the analysts becoming a bit more optimistic in their predictions for losses per share, even though the revenue numbers were unchanged.
View our latest analysis for InnoScience (Suzhou) Technology Holding
There's been no major changes to the consensus price target of HK$92.29, suggesting that reduced loss estimates are not enough to have a long-term positive impact on the stock's valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic InnoScience (Suzhou) Technology Holding analyst has a price target of HK$115 per share, while the most pessimistic values it at HK$55.08. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.
Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's clear from the latest estimates that InnoScience (Suzhou) Technology Holding's rate of growth is expected to accelerate meaningfully, with the forecast 110% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 50% over the past year. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 19% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect InnoScience (Suzhou) Technology Holding to grow faster than the wider industry.
The Bottom Line
The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for InnoScience (Suzhou) Technology Holding going out to 2028, and you can see them free on our platform here.
And what about risks? Every company has them, and we've spotted 1 warning sign for InnoScience (Suzhou) Technology Holding you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.